What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 6 minute read Healthcare Industry News Nexalin Technology unveils breakthrough Alzheimer’s study validating non-drug Gen-2 SYNC brain stimulation Find out how Nexalin’s Gen-2 SYNC device improved cognition in Alzheimer’s patients with non-drug 40 Hz brain stimulation. bySoujanya RaviOctober 8, 2025